Table of Contents

company-logo

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Agile Therapeutics Dividend Announcement

• Agile Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Agile Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Agile Therapeutics Dividend History

Agile Therapeutics Dividend Yield

Agile Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Agile Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Agile Therapeutics Financial Ratios

P/E ratio-0.65
PEG ratio-0.12
P/B ratio-0.47
ROE104.04%
Payout ratio0.00%
Current ratio0.55
Quick ratio0.33
Cash Ratio0.11

Agile Therapeutics Dividend FAQ

Does Agile Therapeutics stock pay dividends?
Agile Therapeutics does not currently pay dividends to its shareholders.
Has Agile Therapeutics ever paid a dividend?
No, Agile Therapeutics has no a history of paying dividends to its shareholders. Agile Therapeutics is not known for its dividend payments.
Why doesn't Agile Therapeutics pay dividends?
There are several potential reasons why Agile Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Agile Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Agile Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Agile Therapeutics a dividend aristocrat?
Agile Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Agile Therapeutics a dividend king?
Agile Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Agile Therapeutics a dividend stock?
No, Agile Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Agile Therapeutics stocks?
To buy Agile Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Agile Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.